Innovent Technologies is redefining the landscape of contract machining and manufacturing with precision, efficiency, and adaptability.
Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...
TipRanks on MSN3d
Innovent Biologics’ SYCUME® Gains Approval as China’s First IGF-1R Antibody for Thyroid Eye DiseaseAn announcement from Innovent Biologics ( ($HK:1801) ) is now available. Innovent Biologics has announced the approval of SYCUME®, China’s first ...
As global markets grapple with inflation concerns and trade policy uncertainties, Asian tech stocks are capturing attention amid shifting economic dynamics. In this environment, identifying ...
Hosted on MSN2mon
Innovent and Roche link on lung cancer therapy development"Innovent and Roche link on lung cancer therapy development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, ...
(Bloomberg) -- Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing promise in treating several types of tumor, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results